Therapy Areas: Cardiovascular
22 March 2019 - - South Korea-based Samsung Bioepis Co., Ltd has received findings of a three-year follow-up study comparing biosimilar Ontruzant (trastuzumab) and reference medicine trastuzumab in ea...
22 March 2019 - Heart failure treatment company Impulse Dynamics reported on Thursday the receipt of approval from the US Food and Drug Administration for its first-in-class Optimizer Smart System des...
21 March 2019 - Global healthcare company Novo Nordisk A/S (CPH:NOVOB) announced on Wednesday the submission of two New Drug Applications (NDAs) to the US Food and Drug Administration (FDA) for oral s...
21 March 2019 - Biopharmaceutical company Innovent Biologics Inc (HKEX:01801) reported on Wednesday the start of treatment of the first patient under its Phase IIa clinical study of IBI306 for the tre...
20 March 2019 - - Positive results from a pre-specified sub-analysis of the Phase III DECLARE-TIMI 58 trial showed that Farxiga (dapagliflozin) reduced the relative risk of major adverse cardiovascula...
19 March 2019 - AstraZeneca Plc (LON:AZN), a global, science-led biopharmaceutical company, announced on Monday the grant by the US Food and Drug Administration (FDA) of Orphan Drug Designation (ODD) ...
Related Headlines